IL-1α correlates with severity of hepatitis C virus-related liver diseases

References

• ZaltronSSpinettiABiasiLBaigueraCCastelliFChronic HCV infection: epidemiological and clinical relevanceBMC Infect Dis201212Suppl 2S223173556
   PubMed Web of Science ®Google Scholar
• PerzJFArmstrongGLFarringtonLAHutinYJBellBPThe contributions of hepatitis B virus and hepatitis C virus to cirrhosis and primary liver cancer worldwideJ Hepatol200645452953816879891
   PubMed Web of Science ®Google Scholar
• ThomasEGhanyMGLiangTJThe application and mechanism of action of ribavirin in therapy of hepatitis CAntivir Chem Chemother2013231112
   Google Scholar
• MohamoudYAMumtazGRRiomeSMillerDAbu-RaddadLJThe epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesisBMC Infect Dis20131328823799878
   PubMed Web of Science ®Google Scholar
• ElwanNElfertAAbd-ElsalamSStudy of hepatic steatosis index in patients with chronic HCV infectionInt J Curr Microbiol App Sci201655266274
   Google Scholar
• Abd-ElsalamSSharaf-EldinMSolimanSElfertABadawiRAhmadYKEfficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practiceArch Virol20181631515628983675
   PubMed Web of Science ®Google Scholar
• AhmedOAKaisarHHHawashNEfficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in treatment of a cohort of Egyptian patients with hepatitis C virus infectionInfect Disord Drug Targets20171729510028413993
   PubMedGoogle Scholar
• AhmedOAElsebaeyMAFouadMHAOutcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infectionInfect Drug Resist20181144144529628768
   PubMed Web of Science ®Google Scholar
• AhmedOAKaisarHHBadawiREfficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infectionInfect Drug Resist20181129529829535545
   PubMed Web of Science ®Google Scholar
• BatallerRBrennerDALiver fibrosisJ Clin Invest2005115220921815690074
   PubMed Web of Science ®Google Scholar
• GalambosJTAlcoholic liver disease, fatty liver and cirrhosisBerkJEHaubrichWSKalserMHRothJLASchaffnerFBockus Gastroenterology4th edPhiladelphiaWB Saunders198529853048
   Google Scholar
• TsochatzisEAGermaniGBurroughsAKTransarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatmentSemin Oncol2010372899320494700
   PubMed Web of Science ®Google Scholar
• FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
   PubMed Web of Science ®Google Scholar
• ZiadaDHEl SadanySSolimanHPrevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: a single center studyJ Egypt Natl Canc Inst201628425726227378258
   PubMed Web of Science ®Google Scholar
• ShetaEEl-KallaFEl-GharibMComparison of single-session transarterial chemoembolization combined with microwave ablation or radiofrequency ablation in the treatment of hepatocellular carcinoma: a randomized-controlled studyEur J Gastroenterol Hepatol201628101198120327362551
   PubMed Web of Science ®Google Scholar
• SpenglerULechmannMIrrgangBDumoulinFLSauerbruchTImmune responses in hepatitis C virus infectionJ Hepatol199624Suppl 220258836885
   PubMed Web of Science ®Google Scholar
• LechmannMIhlenfeldHGBraunschweigerIT and B cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and healthy seropositivesHepatology19962447907958855177
   PubMed Web of Science ®Google Scholar
• ThimmteROldachDChangKMSteigerCRaySCChisariFVDeterminants of viral clearance and persistence during acute hepatitis C virus infectionJ Exp Med2001194101395140611714747
   PubMed Web of Science ®Google Scholar
• McClainCJBarveSDeaciucIKugelmasMHillDCytokines in alcoholic liver diseaseSemin Liver Dis199919220521910422201
   PubMed Web of Science ®Google Scholar
• FalascaKUcciferriCDalessandroMCytokine patterns correlate with liver damage in patients with chronic hepatitis B and CAnn Clin Lab Sci200636214415016682509
   PubMed Web of Science ®Google Scholar
• SchmidtJBlumHEThimmeRT-cell responses in hepatitis B and C virus infection: similarities and differencesEmerg Microbes Infect201323e1526038456
   PubMed Web of Science ®Google Scholar
• DinarelloCAProinflammatory cytokinesChest2000118250350810936147
   PubMed Web of Science ®Google Scholar
• DumoulinFLLeifeldLHoneckerUSauerbruchTSpenglerUIntrahepatic expression of interleukin-1 beta and tumor necrosis factor alpha in chronic hepatitis CJ Infect Dis199918051704170810515837
   PubMed Web of Science ®Google Scholar
• KaplanskiGFarnarierCPayanMJBongrandPDurandJMIncreased levels of soluble adhesion molecules in the serum of patients with hepatitis C. Correlation with cytokine concentrations and liver inflammation and fibrosisDig Dis Sci19974211227722849398806
   PubMed Web of Science ®Google Scholar
• IchikawaTNakaoKNakataKInvolvement of IL-1β and IL-10 in IFN-α-mediated antiviral gene induction in human hepatoma cellsBiochem Biophys Res Commun2002294241442212051728
   PubMed Web of Science ®Google Scholar
• BrodyDTDurumSKMembrane IL-1: IL-1 alpha precursor binds to the plasma membrane via a lectin-like interactionJ Immunol19891434118311872787357
   PubMed Web of Science ®Google Scholar
• Kurt-JonesEABellerDIMizelSBUnanueERIdentification of a membrane-associated interleukin 1 in macrophagesProc Natl Acad Sci U S A1985824120412083919388
   PubMed Web of Science ®Google Scholar
• LinDLeiLLiuYMembrane IL1α inhibits the development of hepatocellular carcinoma via promoting T- and NK-cell activationCancer Res201676113179318827206848
   PubMed Web of Science ®Google Scholar
• KasprzakAZabelZBiczyskoWExpression of cytokines (TNF-α, IL-1α, and IL-2) in chronic hepatitis C: comparative hybridocytochemical and immunocytochemical study in children and adult patientsJ Histochem Cytochem2004521293814688215
   PubMed Web of Science ®Google Scholar
• YuASKeeffeEBManagement of hepatocellular carcinomaRev Gastroenterol Disord200331924
   Google Scholar
• MurakamiTKimTTakahashiSNakamuraHHepatocellular carcinoma multidetector row helical CTAbdom Imaging200227213914611847573
   PubMedGoogle Scholar
• KozielMJCytokines in viral hepatitis CSemin Liver Dis199919215716910422198
   PubMed Web of Science ®Google Scholar
• LecubeAHernándezCGenescàJSimóRProinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patientsDiabetes Care20062951096110116644643
   PubMed Web of Science ®Google Scholar
• WangYKatoNHoshidaYInterleukin-1β gene polymorphisms associated with hepatocellular carcinoma in hepatitis Cvirus infectionHepatology2003371657112500190
   PubMed Web of Science ®Google Scholar
• VanisNMehmedovicAMesihovicRUse of serum levels of pro-inflammatory cytokine IL-1α in chronic hepatitis CColl Antropol2015391757926040073
   PubMedGoogle Scholar
• HuangYSHwangSJChanCYSerum levels of cytokines in hepatitis C-related liver diseaseZhonghua Yi Xue Za Zhi (Taipei)199962632733310389289
   PubMedGoogle Scholar
• BudhuAWangXWThe role of cytokines in hepatocellular carcinomaJ Leukoc Biol20068061197121316946019
   PubMed Web of Science ®Google Scholar
• LinDLeiLLiuYMembrane IL-1α inhibits the development of hepatocellular carcinoma via promoting T and NK cell activationCancer Res201676113179318827206848
   PubMed Web of Science ®Google Scholar
• OlteanuSKandel-KfirMShaishALack of interleukin-1α in Kupffer cells attenuates liver inflammation and expression of inflammatory cytokines in hypercholesterolaemic miceDig Liver Dis201446543343924582082
   PubMedGoogle Scholar
• TseilikmanVKozochkinDSynitskyADoes stress-induced release of interleukin-1 cause liver injury?Cell Mol Neurobiol20123271069107822869351
   PubMed Web of Science ®Google Scholar